Annual Shareholders Equity
$160.50 M
+$101.92 M+173.95%
December 31, 2023
Summary
- As of February 8, 2025, TGTX annual stockholders equity is $160.50 million, with the most recent change of +$101.92 million (+173.95%) on December 31, 2023.
- During the last 3 years, TGTX annual shareholders equity has fallen by -$358.85 million (-69.10%).
- TGTX annual shareholders equity is now -69.10% below its all-time high of $519.35 million, reached on December 31, 2020.
Performance
TGTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$192.16 M
+$14.59 M+8.22%
September 30, 2024
Summary
- As of February 8, 2025, TGTX quarterly stockholders equity is $192.16 million, with the most recent change of +$14.59 million (+8.22%) on September 30, 2024.
- Over the past year, TGTX quarterly shareholders equity has increased by +$32.05 million (+20.02%).
- TGTX quarterly shareholders equity is now -63.00% below its all-time high of $519.35 million, reached on December 31, 2020.
Performance
TGTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TGTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +173.9% | +20.0% |
| 3 y3 years | -69.1% | +375.0% |
| 5 y5 years | +567.8% | +375.0% |
TGTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | +173.9% | -19.0% | +600.5% |
| 5 y | 5-year | -69.1% | +315.6% | -63.0% | >+9999.0% |
| alltime | all time | -69.1% | +2465.5% | -63.0% | +845.0% |
TG Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $192.16 M(+8.2%) |
| Jun 2024 | - | $177.57 M(+10.9%) |
| Mar 2024 | - | $160.11 M(-0.2%) |
| Dec 2023 | $160.50 M(+174.0%) | $160.50 M(-2.6%) |
| Sep 2023 | - | $164.77 M(+307.3%) |
| Jun 2023 | - | $40.45 M(+47.5%) |
| Mar 2023 | - | $27.43 M(-53.2%) |
| Dec 2022 | $58.59 M(-75.3%) | $58.59 M(-41.7%) |
| Sep 2022 | - | $100.48 M(-22.1%) |
| Jun 2022 | - | $129.03 M(-24.3%) |
| Mar 2022 | - | $170.39 M(-28.2%) |
| Dec 2021 | $237.15 M(-54.3%) | $237.15 M(-23.9%) |
| Sep 2021 | - | $311.52 M(-18.7%) |
| Jun 2021 | - | $383.13 M(-14.0%) |
| Mar 2021 | - | $445.29 M(-14.3%) |
| Dec 2020 | $519.35 M(+1244.9%) | $519.35 M(+204.3%) |
| Sep 2020 | - | $170.66 M(-12.1%) |
| Jun 2020 | - | $194.23 M(<-9900.0%) |
| Mar 2020 | - | -$1.35 M(-103.5%) |
| Dec 2019 | $38.62 M(+60.7%) | $38.62 M(-249.7%) |
| Sep 2019 | - | -$25.79 M(-295.3%) |
| Jun 2019 | - | $13.21 M(-31.4%) |
| Mar 2019 | - | $19.25 M(-19.9%) |
| Dec 2018 | $24.04 M(-64.1%) | $24.04 M(-66.5%) |
| Sep 2018 | - | $71.74 M(-29.2%) |
| Jun 2018 | - | $101.38 M(+18.9%) |
| Mar 2018 | - | $85.23 M(+27.2%) |
| Dec 2017 | $66.99 M(+86.8%) | $66.99 M(-15.8%) |
| Sep 2017 | - | $79.55 M(+2.0%) |
| Jun 2017 | - | $77.97 M(-22.8%) |
| Mar 2017 | - | $101.04 M(+181.7%) |
| Dec 2016 | $35.87 M(-64.7%) | $35.87 M(-36.8%) |
| Sep 2016 | - | $56.75 M(-27.9%) |
| Jun 2016 | - | $78.70 M(-12.0%) |
| Mar 2016 | - | $89.45 M(-11.9%) |
| Dec 2015 | $101.57 M(+26.8%) | $101.57 M(-12.7%) |
| Sep 2015 | - | $116.31 M(+3.0%) |
| Jun 2015 | - | $112.95 M(+6.3%) |
| Mar 2015 | - | $106.23 M(+32.6%) |
| Dec 2014 | $80.10 M(+100.0%) | $80.10 M(+19.4%) |
| Sep 2014 | - | $67.08 M(+28.8%) |
| Jun 2014 | - | $52.10 M(-4.3%) |
| Mar 2014 | - | $54.43 M(+35.9%) |
| Dec 2013 | $40.05 M(+157.6%) | $40.05 M(-10.3%) |
| Sep 2013 | - | $44.64 M(+334.4%) |
| Jun 2013 | - | $10.28 M(-30.1%) |
| Mar 2013 | - | $14.70 M(-5.5%) |
| Dec 2012 | $15.55 M(+61.6%) | $15.55 M(+65.9%) |
| Sep 2012 | - | $9.37 M(-14.9%) |
| Jun 2012 | - | $11.02 M(-6.2%) |
| Mar 2012 | - | $11.74 M(+22.0%) |
| Dec 2011 | $9.62 M(-279.4%) | $9.62 M(-3367.0%) |
| Sep 2011 | - | -$294.60 K(-86.3%) |
| Jun 2011 | - | -$2.15 M(+65.0%) |
| Mar 2011 | - | -$1.30 M(-75.7%) |
| Dec 2010 | -$5.36 M | -$5.36 M(-6.5%) |
| Sep 2010 | - | -$5.74 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -$5.78 M(-23.1%) |
| Mar 2010 | - | -$7.52 M(+10.8%) |
| Dec 2009 | -$6.79 M(+55.1%) | -$6.79 M(+2.1%) |
| Sep 2009 | - | -$6.64 M(+5.4%) |
| Jun 2009 | - | -$6.31 M(+26.1%) |
| Mar 2009 | - | -$5.00 M(+14.3%) |
| Dec 2008 | -$4.38 M(+391.1%) | -$4.38 M(-8.0%) |
| Sep 2008 | - | -$4.76 M(+38.0%) |
| Jun 2008 | - | -$3.45 M(+1052.8%) |
| Mar 2008 | - | -$299.00 K(-66.4%) |
| Dec 2007 | -$891.10 K(-159.2%) | -$891.10 K(-257.3%) |
| Sep 2007 | - | $566.60 K(-79.4%) |
| Jun 2007 | - | $2.75 M(-61.6%) |
| Mar 2007 | - | $7.14 M(+374.8%) |
| Dec 2006 | $1.50 M(-84.2%) | $1.50 M(-61.4%) |
| Sep 2006 | - | $3.90 M(-28.7%) |
| Jun 2006 | - | $5.47 M(-22.1%) |
| Mar 2006 | - | $7.03 M(-26.3%) |
| Dec 2005 | $9.54 M(+114.2%) | $9.54 M(-15.3%) |
| Sep 2005 | - | $11.26 M(+1267.6%) |
| Jun 2005 | - | $823.70 K(-73.6%) |
| Mar 2005 | - | $3.12 M(-29.9%) |
| Dec 2004 | $4.45 M(-34.8%) | $4.45 M(-27.6%) |
| Sep 2004 | - | $6.15 M(-26.1%) |
| Jun 2004 | - | $8.32 M(-9.5%) |
| Mar 2004 | - | $9.20 M(+34.6%) |
| Dec 2003 | $6.83 M(+971.2%) | $6.83 M(-1027.8%) |
| Sep 2003 | - | -$736.50 K(-128.9%) |
| Jun 2003 | - | $2.55 M(-23.0%) |
| Mar 2003 | - | $3.31 M(+419.1%) |
| Dec 2002 | $637.90 K(-49.0%) | $637.90 K(+1359.7%) |
| Sep 2002 | - | $43.70 K(-93.1%) |
| Jun 2002 | - | $630.40 K(+7.7%) |
| Mar 2002 | - | $585.40 K(-53.2%) |
| Dec 2001 | $1.25 M(+151.9%) | $1.25 M(-1038.9%) |
| Sep 2001 | - | -$133.10 K(-125.5%) |
| Jun 2001 | - | $522.90 K(-76.0%) |
| Mar 2001 | - | $2.18 M(+338.9%) |
| Dec 2000 | $496.10 K(-85.4%) | $496.10 K(-75.5%) |
| Sep 2000 | - | $2.03 M(-5.1%) |
| Jun 2000 | - | $2.13 M(-36.3%) |
| Mar 2000 | - | $3.35 M(-1.5%) |
| Dec 1999 | $3.40 M(-42.4%) | $3.40 M(-15.0%) |
| Sep 1999 | - | $4.00 M(-7.0%) |
| Jun 1999 | - | $4.30 M(-14.0%) |
| Mar 1999 | - | $5.00 M(-15.3%) |
| Dec 1998 | $5.90 M(-29.8%) | $5.90 M(-16.9%) |
| Sep 1998 | - | $7.10 M(-13.4%) |
| Jun 1998 | - | $8.20 M(+13.9%) |
| Mar 1998 | - | $7.20 M(-14.3%) |
| Dec 1997 | $8.40 M(+300.0%) | $8.40 M(-15.2%) |
| Sep 1997 | - | $9.90 M(+350.0%) |
| Jun 1997 | - | $2.20 M(+69.2%) |
| Mar 1997 | - | $1.30 M(-38.1%) |
| Dec 1996 | $2.10 M | $2.10 M(-32.3%) |
| Sep 1996 | - | $3.10 M(+24.0%) |
| Jun 1996 | - | $2.50 M |
FAQ
- What is TG Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for TG Therapeutics?
- What is TG Therapeutics annual shareholders equity year-on-year change?
- What is TG Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for TG Therapeutics?
- What is TG Therapeutics quarterly shareholders equity year-on-year change?
What is TG Therapeutics annual stockholders equity?
The current annual shareholders equity of TGTX is $160.50 M
What is the all time high annual shareholders equity for TG Therapeutics?
TG Therapeutics all-time high annual stockholders equity is $519.35 M
What is TG Therapeutics annual shareholders equity year-on-year change?
Over the past year, TGTX annual stockholders equity has changed by +$101.92 M (+173.95%)
What is TG Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TGTX is $192.16 M
What is the all time high quarterly shareholders equity for TG Therapeutics?
TG Therapeutics all-time high quarterly stockholders equity is $519.35 M
What is TG Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TGTX quarterly stockholders equity has changed by +$32.05 M (+20.02%)